-
-
About PMI
- Welcome to PMI Science
- PMI Science Booklet
- Our Scientists
- The Cube: PMI’s R&D Center
- PMI’s Global Network
- Facts and Figures
About PMIExplore PMI Science, where innovation meets harm reduction. Learn about our scientists, smoke-free research, and commitment to transparency in research.Read More -
Smoke-free approach
- Harm Reduction
- Absence of Combustion
- Nicotine
- Cigarette Tar
- Tobacco regulation
- Harmful Chemicals Measured
Smoke-free approachPMI offers smoke-free alternatives with the potential to reduce the risk of harm for adult smokers who do not quit. Learn about harm reduction, the role of nicotine, and the regulation of smoke-free products.Read More -
Research
- PMI’s studies on smoke-free products
- Our findings
- PMI Publications Library
- Literature reviews
- Independent studies
- Investigator Initiated Studies
ResearchDiscover PMI's rigorous scientific approach to smoke-free products and product assessment. Dive into our research results, peer-reviewed publications, independent research, and expert reports.Read More -
Our Products
- Heated tobacco products
- E-cigarettes and vaping products
- Nicotine pouches
- Nicotine Salts Product
Our ProductsPMI believes that offering a range of smoke-free alternatives is essential to ensure individual smokers are able to find a smoke-free product that they can fully switch to.Read More -
News & Events
- Scientific Update magazine
- Open Science events
- News
- Conferences calendar
News & EventsExplore the latest insights and stay informed about upcoming events and conference presentations from PMI scientists.Read More - Contact Us
-
About PMI
Innovation of Reduced Risk Alternatives: Oral Tobacco and Nicotine Products
Gunduz, N.
Recent technological developments of new smoke-free products such as heated tobacco products, e-vapor products, and oral nicotine pouches that have the potential to provide nicotine with fewer and lower levels of harmful chemicals compared with combustible products like cigarettes have made it possible to offer a portfolio of smoke-free products to adult smokers who would otherwise continue to smoke as alternatives to cigarettes and other combusted products.
Nicotine pouches are a relatively new addition to the market of oral nicotine products and have been present on the U.S. market since 2016 and in Europe since 2018. These pouches are similar to snus but do not contain tobacco. Instead, nicotine pouches contain tobacco-derived or synthetic nicotine, flavorings, and other ingredients.
The scientific assessment of oral products, like nicotine pouches, that substantiates the reduced-risk potential includes characterization of the chemical composition of the product, pre-clinical and clinical toxicological assessments, and product use characterization.
In this presentation we discuss the low-risk potential of nicotine pouches and their place in the risk continuum of tobacco and nicotine-containing products.
Assessing the impact of switching to the Tobacco Heating System on cardiovascular diseases: Translating basic science into clinical benefit
Scientific Update October 2024 Issue 20
A comparative assessment of HPHC yields and in vitro toxicity for 1R6F reference cigarette smoke versus aerosol generated by Tobacco Heating System 3.0
Effect of Switching From Cigarette Smoking to THS on Disease Progression in Mild to Moderate COPD Subjects With Chronic Bronchitis Symptoms
Community-Reviewed Biological Network Models for Toxicology and Drug Discovery Applications
Verification Of Systems Biology Research In The Age Of Collaborative - Competition
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.